Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVERsal to Normoglycemia by Treating PREDIABETES: The REVERT-PREDIABETES Trial

NCT07392151 is registered in ClinicalTrials.gov with Michael Mæng as lead sponsor.

NCT NCT07392151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07392151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVERsal to Normoglycemia by Treating PREDIABETES: The REVERT-PREDIABETES Trial
Lead sponsor
Michael Mæng
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
October 31, 2029
Enrollment
158 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome, prediabetes